Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2010
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010112936A1 P38map kinase inhibitor
10/07/2010WO2010112178A1 Method for producing pyridyl-substituted pyrazoles
10/07/2010WO2010112177A1 Acylated aminopyridines and aminopyridazines as insecticides
10/07/2010WO2010112124A1 Autotaxin inhibitors
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010WO2010111948A1 Arylmethylamine compounds, preparation methods and pharmaceutical uses thereof
10/07/2010WO2009090237A3 Fungicide hydroximoyl-tetrazole derivatives
10/07/2010US20100256382 Tri-aryl compounds and compositions comprising the same
10/07/2010US20100256381 Process for producing cisatracurium and associated intermediates
10/07/2010US20100256375 Substituted benzimidazoles and methods of preparation
10/07/2010US20100256374 Novel process
10/07/2010US20100256373 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256365 Compounds and methods for kinase modulation, and indications therefor
10/07/2010US20100256364 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
10/07/2010US20100256359 Hetero isonipecotic modulators of vanilloid vr1 receptor
10/07/2010US20100256357 Heterocycles useful as inhibitors of carbonic anhydrase
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256198 Method for decreasing symptoms of alcohol consumption
10/07/2010US20100256195 Tetrazole-substituted anthranilamides as pesticides
10/07/2010US20100256192 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
10/07/2010US20100256189 Piperidine derivative
10/07/2010US20100256188 New compounds
10/07/2010US20100256186 Sulfonyl-piperidin-4-yl methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/07/2010US20100256185 Crystalline forms of a biphenyl compound
10/07/2010US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
10/07/2010US20100256172 Heteroaryls and uses thereof
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256152 Novel pharmaceutical composition for treatment of schizophrenia
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256126 Piperidine derivatives as nk3 receptor antagonists
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256113 Quinolone derivative
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010US20100255504 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/07/2010US20100255106 Benzothiophenes, formulations containing same, and methods
10/07/2010US20100255096 Compositions And Methods For Transmucosal Delivery Of Domperidone
10/07/2010US20100252820 Light emitting cu (i) complexes
10/07/2010CA2757415A1 Autotaxin inhibitors
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756870A1 Substituted indolo-pyridinone compounds
10/07/2010CA2754609A1 P38map kinase inhibitor
10/06/2010EP2236507A1 N-pyrazole-2-pyridinecarboxamide derivative
10/06/2010EP2236506A1 Compound having triazine ring structure substituted with group and organic electroluminescent device
10/06/2010EP2236505A1 Acylated aminopyridines and pyridazines as insecticides
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2235003A1 Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
10/06/2010EP2235002A1 4-pyridinone compounds and their use for cancer
10/06/2010EP2235001A1 4-pyridinone compounds and their use for cancer
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP2234998A2 Specific inhibitors of pteridine reductase with antiparasitic action
10/06/2010EP2234997A1 Process for the preparation of pyrido ý2,1-a¨isoquinoline derivatives
10/06/2010EP2234984A1 Fluoroalkyl substituted benzimidazole cannabinoid agonists
10/06/2010EP2234981A1 Novel imidazole-substituted arylamides
10/06/2010EP2234978A1 Carbamoyl compounds as dgat1 inhibitors 190
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234976A1 Novel pyrazole-substituted arylamides
10/06/2010EP2234969A2 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials
10/06/2010EP2234968A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP1874760B1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010EP1309569B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN101855220A Drug active in neuropathic pain
10/06/2010CN101855219A 6, 11-bridged biaryl macrolides
10/06/2010CN101855206A N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
10/06/2010CN101851229A N-substituted pyridine acyl-N-substituted pyrimidyl thiourea derivant as well as preparation and application thereof
10/06/2010CN101851211A Novel piperazinoamide compound
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807837 Scalable synthesis of imidazole derivatives
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807679 2-chloro-N-(4-chloro-2-{4-[(E)-3-(4-chloro-phenyl)-allyl]-piperazin-1-yl}-phenyl)-isonicotinamide; for insects, acarines, nematodes and molluscs